相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience
Irene Gagliardi et al.
CALCIFIED TISSUE INTERNATIONAL (2022)
2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
Dimitrios Farmakis et al.
HEMASPHERE (2022)
Factors of mineral homeostasis impairment and bone mineral density loss in women with central hypogonadism
I. Ilovayskaya et al.
CLIMACTERIC (2020)
Impact of iron overload on bone remodeling in thalassemia
Pokpong Piriyakhuntorn et al.
ARCHIVES OF OSTEOPOROSIS (2020)
Bone Metabolism Markers in Thalassemia Major-Induced Osteoporosis: Results from a Cross-Sectional Observational Study
Athanasios N. Tsartsalis et al.
CURRENT MOLECULAR MEDICINE (2019)
Comparative effectiveness of alendronate and zoledronic acid on bone mass improvement in transfusion-dependent thalassemia patients
Omid Reza Zekavat et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2019)
Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience
Agostino Gaudio et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2019)
Turner syndrome and osteoporosis
Areti Augoulea et al.
MATURITAS (2019)
The role of biphosphonates in the management of thalassemia-induced osteoporosis: a systematic review and meta-analysis
Athanasios N. Tsartsalis et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2018)
Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial
Ersi Voskaridou et al.
BLOOD ADVANCES (2018)
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis
Nunziata Morabito et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2016)
Management of beta-thalassemia-associated osteoporosis
Andrea Giusti et al.
COOLEY'S ANEMIA (2016)
Thalassemic osteopathy: A new marker of bone deposition
M. Baldini et al.
BLOOD CELLS MOLECULES AND DISEASES (2014)
Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials
Andrea Giusti
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions
Nick Bishop et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study
Gian Luca Forni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Treatment failure in osteoporosis
A. Diez-Perez et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Bone Mass in Subjects with Klinefelter Syndrome: Role of Testosterone Levels and Androgen Receptor Gene CAG Polymorphism
Alberto Ferlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The lively cytokines network in β-Thalassernia Major-related osteoporosis
Nunziata Morabito et al.
BONE (2007)
Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial
Zaher K. Otrock et al.
ANNALS OF HEMATOLOGY (2006)
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: The Fracture Intervention Trial
DC Bauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia
E Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with β-thalassaemia disease
P Mahachoklertwattana et al.
CLINICAL ENDOCRINOLOGY (2003)
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
SR Cummings et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Bisphosphonates in the treatment of thalassemia-induced osteoporosis
N Morabito et al.
OSTEOPOROSIS INTERNATIONAL (2002)